Stockscreener 앱 받기
2.62
1.16%
0.03
전일 마감가:
$2.59
열려 있는:
$2.57
하루 거래량:
135.09K
Relative Volume:
0.58
시가총액:
$90.89M
수익:
$50.23M
순이익/손실:
$-36.40M
주가수익비율:
-2.2017
EPS:
-1.19
순현금흐름:
$-27.10M
1주 성능:
+2.34%
1개월 성능:
-20.36%
6개월 성능:
-59.57%
1년 성능:
-61.75%
1일 변동 폭
$2.57
$2.71
1주일 범위
$2.52
$2.87
52주 변동 폭
$2.19
$12.51
908 디바이시스 Stock (MASS) Company Profile
명칭
908 Devices Inc
전화
978-729-4478
주소
645 SUMMER STREET, BOSTON
MASS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
2.62 | 90.89M | 50.23M | -36.40M | -27.10M | -1.19 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
908 디바이시스 Stock (MASS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | 개시 | Stephens | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-01-12 | 개시 | Cowen | Outperform |
| 2021-01-12 | 개시 | SVB Leerink | Outperform |
| 2021-01-12 | 개시 | Stifel | Buy |
| 2021-01-12 | 개시 | William Blair | Outperform |
모두보기
908 디바이시스 주식(MASS)의 최신 뉴스
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
Analysts Have Lowered Expectations For 908 Devices Inc. (NASDAQ:MASS) After Its Latest Results - Yahoo Finance
FY2024 EPS Estimates for 908 Devices Cut by Leerink Partnrs - MarketBeat
Granahan Investment Management Reduces Stake in 908 Devices Inc - GuruFocus.com
Leerink Partners Reaffirms “Market Perform” Rating for 908 Devices (NASDAQ:MASS) - Defense World
Leerink Partnrs Downgrades 908 Devices (NASDAQ:MASS) to Hold - Defense World
FY2024 EPS Estimates for 908 Devices Lifted by William Blair - MarketBeat
908 Devices Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Boston firm to shift manufacturing to North Carolina - The Business Journals
908 Devices downgraded to Market Perform from Outperform at Leerink - TipRanks
Earnings call: 908 Devices adjusts revenue guidance amid market challenges - Investing.com
Leerink downgrades 908 Devices stock rating on market headwinds, slashes PT - Investing.com
908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Call Transcript - Insider Monkey
Leerink Partners Reaffirms Market Perform Rating for 908 Devices (NASDAQ:MASS) - MarketBeat
908 Devices price target lowered to $6 from $17 at Stifel - TipRanks
908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges - GuruFocus.com
908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges By GuruFocus - Investing.com Canada
908 Devices Inc. Reports Q3 2024 Financial Results - TipRanks
908 Devices stock hits 52-week low at $3.12 amidst market challenges - Investing.com Canada
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook - BioSpace
908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates - MSN
908 Devices Restructures for Cost Efficiency and Growth - TipRanks
908 Devices Inc. (MASS) Quarterly 10-Q Report - Quartz
908 Devices Inc. Intends to Transition All Manufacturing Operations Currently Undertaken in Boston, Massachusetts to Its Facilities in Morrisville, North Carolina and Danbury, Connecticut - Marketscreener.com
What To Expect From 908 Devices Inc (MASS) Q3 2024 Earnings - GuruFocus.com
908 Devices (MASS) Set to Announce Quarterly Earnings on Tuesday - Defense World
ARK Investment Management LLC Sells 718,082 Shares of 908 Devices Inc. (NASDAQ:MASS) - MarketBeat
US Penny Stocks: 908 Devices Leads This Trio - Simply Wall St
Recent uptick might appease 908 Devices Inc. (NASDAQ:MASS) institutional owners after losing 41% over the past year - Simply Wall St
908 Devices (MASS) Scheduled to Post Earnings on Tuesday - MarketBeat
908 Devices to Participate in Upcoming Investor Conferences - BioSpace
908 Devices stock hits 52-week low at $3.24 amid market challenges - Investing.com Australia
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 - Business Wire
Investor presentation (10/21/2024 04: 00 - Marketscreener.com
908 Devices (NASDAQ:MASS) PT Lowered to $12.00 at Leerink Partners - Defense World
Leerink Partners Lowers 908 Devices (NASDAQ:MASS) Price Target to $12.00 - MarketBeat
Millennium Management LLC Increases Stock Holdings in 908 Devices Inc. (NASDAQ:MASS) - MarketBeat
908 Devices stock hits 52-week low at $3.35 amid market challenges - Investing.com
908 Devices Inc (MASS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - Yahoo Finance
HazSim Enters South American Market with New Partner - Firehouse
908 Devices Inc. (NASDAQ:MASS) Shares Acquired by American Century Companies Inc. - Defense World
908 디바이시스 (MASS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
908 디바이시스 주식 (MASS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Eisenberg Marcia | Director |
Jun 07 '24 |
Option Exercise |
0.00 |
682 |
0 |
6,816 |
| Knopp Kevin J. | President and CEO |
May 13 '24 |
Buy |
6.42 |
10,000 |
64,200 |
508,981 |
| Knopp Kevin J. | President and CEO |
May 10 '24 |
Buy |
5.77 |
10,000 |
57,700 |
498,981 |
| Knopp Kevin J. | President and CEO |
May 09 '24 |
Buy |
5.83 |
10,000 |
58,300 |
488,981 |
| Knopp Kevin J. | President and CEO |
May 08 '24 |
Buy |
5.72 |
10,000 |
57,200 |
478,981 |
| Knopp Kevin J. | President and CEO |
May 07 '24 |
Buy |
5.60 |
10,000 |
56,000 |
468,981 |
| Knopp Kevin J. | President and CEO |
Apr 16 '24 |
Option Exercise |
1.75 |
47,000 |
82,250 |
458,981 |
| Brown Christopher D. | Chief Product Officer |
Apr 01 '24 |
Option Exercise |
1.75 |
3,600 |
6,300 |
884,994 |
| Griffith Joseph H. IV | Chief Financial Officer |
Mar 26 '24 |
Option Exercise |
1.58 |
8,437 |
13,330 |
93,437 |
| Griffith Joseph H. IV | Chief Financial Officer |
Feb 02 '24 |
Sale |
7.09 |
9,711 |
68,873 |
80,000 |
0.65%
자본화:
|
볼륨(24시간):